The rise of drug-resistant pathogens presents a significant challenge to public health, necessitating a united effort among healthcare professionals, policymakers, and the general public. By promoting responsible antimicrobial use, investing in research, and embracing advanced diagnostic technologies, we can work together to tackle this growing threat.

The ongoing global outbreak of H5N1, commonly known as bird flu, continues to affect both wild birds and poultry in the United States and other parts of the world. Though human cases of the virus are still rare, health officials remain concerned about the potential risks to humans given the virus's ability to infect mammals.

As the Omicron subvariant Kraken (XBB.1.5) climbs to 66% of new COVID-19 cases in the U.S., a newer subvariant may be challenging its reign: Orthrus (CH.1.1), named after Greek mythology's two-headed dog monster.